GE HealthCare tops quarterly estimates, weighs patient care unit sale
window 24h
IN SHORT
Several companies have reported strong second-quarter financial results, surpassing analyst expectations. GE HealthCare exceeded profit estimates due to demand for its diagnostic and imaging equipment, though it is considering selling its patient care solutions unit. Biogen also beat expectations, driven by robust sales of rare-disease drugs, and now forecasts full-year revenue growth. Agribusiness firm Bunge Global surpassed Q2 profit estimates and raised its full-year outlook. Additionally, Frontier Airlines projects third-quarter profits above estimates, citing higher airfares and reduced competition.
✉Newsletter
PiQ Daily
Pick your topics. Get only what matters, on your cadence.
Key Numbers
$1.31Bunge Global Q2 adjusted earnings per share
$9.25 to $9.75Bunge Global full-year adjusted profit forecast range
Who's Involved
GE HealthCare
company reporting strong Q2 results and considering unit sale
Bunge Global
agribusiness company exceeding Q2 profit estimates and raising outlook
Biogen
company beating quarterly estimates on rare-disease drug sales
Frontier Airlines
carrier forecasting Q3 profit above estimates due to higher airfares
Spirit Airlines
airline whose market exit contributes to reduced competition for Frontier
1 / 3
Key facts
GE HealthCare reported strong second-quarter results exceeding profit expectations.
GE HealthCare's strong results were driven by demand for diagnostic and imaging equipment and tariff refunds.
GE HealthCare is considering selling its patient care solutions segment due to declining revenue in that unit.
Bunge Global reported second-quarter adjusted earnings of $1.31 per share, surpassing analyst expectations.
Bunge Global raised its full-year adjusted profit forecast to a range of $9.25 to $9.75 per share.
Biogen exceeded second-quarter profit and revenue expectations.
Biogen's strong performance was driven by rare-disease drug sales.
Biogen now forecasts full-year revenue growth, a change from its previous projection of a decline.
Frontier Airlines' positive forecast is driven by higher airfares and reduced competition.
Frontier Airlines aims to offset rising fuel costs with improved pricing power.
Multiple companies have announced second-quarter financial results that exceeded Wall Street's expectations, signaling positive performance across different sectors. GE HealthCare reported strong earnings, driven by robust demand for its diagnostic and imaging equipment, alongside benefits from tariff refunds. Despite this overall success, the company is evaluating the potential sale of its patient care solutions segment, which has experienced declining revenue.
Biogen also surpassed analyst expectations for both profit and revenue in the second quarter. This outperformance is attributed to the strong sales of its rare-disease medicines. Following these positive results, Biogen has revised its full-year forecast, now projecting revenue growth, a notable shift from its prior expectation of a revenue decline.
In the agribusiness sector, Bunge Global reported second-quarter adjusted earnings of $1.31 per share, surpassing analyst predictions. The company has further bolstered its financial outlook by raising its full-year adjusted profit forecast to a range of $9.25 to $9.75 per share.
Looking ahead, Frontier Airlines anticipates its third-quarter earnings will exceed analyst expectations. This positive forecast is supported by anticipated increases in airfares and a reduction in competition, particularly following Spirit Airlines' exit from the market. Frontier aims to leverage this improved pricing power to counteract rising fuel costs.
↳ Why This Matters
Multiple companies have announced second-quarter financial results that exceeded Wall Street's expectations, signaling positive performance across different sectors. GE HealthCare reported strong earnings, driven by robust demand for its diagnostic and imaging equipment, alongside benefits from tariff refunds. Despite this overall success, the company is evaluating the potential sale of its patient care solutions segment, which has experienced declining revenue.
Frequently asked questions
GE HealthCare reported net income of $561 million and revenue of $5.30 billion, exceeding analyst expectations. Adjusted earnings per share were $1.13.
The patient care solutions unit experienced a revenue decline of 13.3% due to profitability and supply issues, prompting a strategic review to determine the best path for long-term growth and value.
The company's net income was significantly boosted by $129 million in tariff refunds, as well as strong demand for its diagnostic and imaging equipment.
Yes, the company raised its full-year 2025 guidance.
What Happens Next
01GE HealthCare will continue its strategic review of the patient care solutions segment.
02The company expects supply improvements to benefit sales and margins in the second half of the year.
03GE HealthCare has raised its full-year 2025 guidance.
Get the newsletter.
Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.
